Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Shackleton

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
Nature Communications|September 30, 2016
Erratum: Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanomaUgur Eskiocak, Vijayashree Ramesh, Jennifer G Gill, et al.
Oncogene|June 21, 2020
The Hippo pathway oncoprotein YAP promotes melanoma cell invasion and spontaneous metastasisXiaomeng Zhang, Lie Yang, Pacman Szeto, et al.
Nature Cell Biology|December 26, 2006
Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiationMarie-Liesse Asselin-Labat, Kate D Sutherland, Holly Barker, et al.
Blood|May 10, 2003
Functional comparison of DCs generated in vivo with Flt3 ligand or in vitro from blood monocytes: differential regulation of function by specific classes of physiologic stimuliMichael Jefford, Max Schnurr, Tracey Toy, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 4, 2025
Tiered approach to molecular testing of thyroid fine needle aspiration samples may improve preoperative diagnosisNelson George, Simon Chu, Stephanie Manning, et al.
BMJ Open|January 23, 2023
Developing an Australian Melanoma Clinical Outcomes Registry (MelCOR): a protocol paperDale Jobson, Benjamin Roffey, Renee Best, et al.
Cancer Immunity|March 10, 2005
Characterization of antigen-specific CD8+ T lymphocyte responses in skin and peripheral blood following intradermal peptide vaccinationQiyuan Chen, Heather Jackson, Mark Shackleton, et al.
European Journal of Cancer (Oxford, England : 1990)|May 19, 2015
Long-term outcome in BRAF(V600E) melanoma patients treated with vemurafenib: Patterns of disease progression and clinical management of limited progressionIgor Puzanov, Ravi K Amaravadi, Grant A McArthur, et al.
The Journal of Investigative Dermatology|December 26, 2025
Evaluation of clonality in lentigo malignaSophie Soyeon Lim, Peinan Zhao, Nicholas C Wong, et al.
Oncogene|March 11, 2023
UHRF1/UBE2L6/UBR4-mediated ubiquitination regulates EZH2 abundance and thereby melanocytic differentiation phenotypes in melanomaGamze Kuser-Abali, Youfang Zhang, Pacman Szeto, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
Nature Communications|September 30, 2016
Erratum: Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanomaUgur Eskiocak, Vijayashree Ramesh, Jennifer G Gill, et al.
Oncogene|June 21, 2020
The Hippo pathway oncoprotein YAP promotes melanoma cell invasion and spontaneous metastasisXiaomeng Zhang, Lie Yang, Pacman Szeto, et al.
Nature Cell Biology|December 26, 2006
Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiationMarie-Liesse Asselin-Labat, Kate D Sutherland, Holly Barker, et al.
Blood|May 10, 2003
Functional comparison of DCs generated in vivo with Flt3 ligand or in vitro from blood monocytes: differential regulation of function by specific classes of physiologic stimuliMichael Jefford, Max Schnurr, Tracey Toy, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 4, 2025
Tiered approach to molecular testing of thyroid fine needle aspiration samples may improve preoperative diagnosisNelson George, Simon Chu, Stephanie Manning, et al.
BMJ Open|January 23, 2023
Developing an Australian Melanoma Clinical Outcomes Registry (MelCOR): a protocol paperDale Jobson, Benjamin Roffey, Renee Best, et al.
Cancer Immunity|March 10, 2005
Characterization of antigen-specific CD8+ T lymphocyte responses in skin and peripheral blood following intradermal peptide vaccinationQiyuan Chen, Heather Jackson, Mark Shackleton, et al.
European Journal of Cancer (Oxford, England : 1990)|May 19, 2015
Long-term outcome in BRAF(V600E) melanoma patients treated with vemurafenib: Patterns of disease progression and clinical management of limited progressionIgor Puzanov, Ravi K Amaravadi, Grant A McArthur, et al.
The Journal of Investigative Dermatology|December 26, 2025
Evaluation of clonality in lentigo malignaSophie Soyeon Lim, Peinan Zhao, Nicholas C Wong, et al.
Oncogene|March 11, 2023
UHRF1/UBE2L6/UBR4-mediated ubiquitination regulates EZH2 abundance and thereby melanocytic differentiation phenotypes in melanomaGamze Kuser-Abali, Youfang Zhang, Pacman Szeto, et al.
Pageof 10